0001179110-20-005830.txt : 20200512 0001179110-20-005830.hdr.sgml : 20200512 20200512174446 ACCESSION NUMBER: 0001179110-20-005830 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200512 FILED AS OF DATE: 20200512 DATE AS OF CHANGE: 20200512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stewart Jeffrey Ryan CENTRAL INDEX KEY: 0001761675 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 20870341 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2020-05-12 0 0001551152 AbbVie Inc. ABBV 0001761675 Stewart Jeffrey Ryan 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 0 1 0 0 SVP, US Commercial Operations Common Stock, $0.01 par value 2020-05-12 4 S 0 23024 90.0022 D 52760 D Common Stock, $0.01 par value 1338 I By spouse in trust The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.01, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person disclaims beneficial ownership of all securities held by his spouse. This sale was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Steven L. Scrogham, attorney-in-fact for Jeffrey R. Stewart 2020-05-12